M.D. Anderson Cancer Center: all 3,044 studies

Page 4 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility StudyRecruitingNCT06162403Not applicable
• Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.RecruitingNCT06162377Phase 4
• A Pilot Study for Pupillary Assessment to Predict CAR-T Related NeurotoxicityRecruitingNCT06144151
• Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast TissueRecruitingNCT06127797
• Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility StudyRecruitingNCT06121232Not applicable
• Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer ScreeningRecruitingNCT06109870Not applicable
• Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular LymphomaRecruitingNCT06108232Phase 2
• Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple MyelomaRecruitingNCT06105554Phase 1/2
• Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)RecruitingNCT06085729Phase 1/2
• Combination Therapy for Cancer Related Fatigue in Patients With Metastatic CancersRecruitingNCT06085716Phase 2/3
• A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical ProstatectomyRecruitingNCT06085664Phase 1/2
• A Randomized Control Trial for Patient Reported Outcomes and Safety in Outpatient Thyroid LobectomyRecruitingNCT06085625Phase 2
• Minimally-invasive Stabilization of Pelvic Metastases With Photodynamic Nails: A Multi-center Prospective Study of Functional OutcomeRecruitingNCT06083896Phase 1
• Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1RecruitingNCT06083883Phase 1
• Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline TherapyRecruitingNCT06083844Phase 2
• NeoAdjuvant Theranostic Lutetium Study: The Nautilus TrialRecruitingNCT06066437Phase 1/2
• Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)RecruitingNCT06066424Phase 1
• Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R MyelomaRecruitingNCT06066359Phase 1/2
• Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100RecruitingNCT06065462Phase 1/2
• A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone MetastasesRecruitingNCT06065449Phase 3
• Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell CarcinomaRecruitingNCT06053658Phase 2
• Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell LymphomaRecruitingNCT06045247Phase 2
• A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular LymphomaRecruitingNCT06043323Phase 2
• Spanish Decision Tool for Ovarian Cancer Maintenance TherapyRecruitingNCT06036810Not applicable
• A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid TumorsRecruitingNCT06006273Phase 1
• Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain: A Prospective, Randomized Pilot StudyRecruitingNCT06004882Not applicable
• A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)RecruitingNCT06004336Phase 2
• Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot StudyRecruitingNCT06004063Not applicable
• Prophylactic Lymphovenous Bypass Procedure Following Inguinal Lymphadenectomy or Pelvic Lymphadenectomy: A Prospective Observational StudyRecruitingNCT05992909
• Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed TherapyRecruitingNCT05985954Phase 1
• A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive CytologyRecruitingNCT05977998Phase 2
• A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic CholangiocarcinomaRecruitingNCT05967182Phase 2
• Data Collection Protocol for Patients With Von Hippel Lindau DiseaseRecruitingNCT05955014
• A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal AdenocarcinomaRecruitingNCT05947838Not applicable
• A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone LymphomaRecruitingNCT05929612Phase 2
• Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced CancerRecruitingNCT05904782
• Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland CancersRecruitingNCT05884320Phase 2
• Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical StudyRecruitingNCT05879146Phase 2
• Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate CancerRecruitingNCT05873192Phase 2
• Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active SurveillanceRecruitingNCT05840484
• A Comparison of Healthcare Provider and Caregiver Perception of Discomfort in Advanced Cancer Patients Who Have a Hypoactive DeliriumRecruitingNCT05837039
• A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)RecruitingNCT05834244Phase 1
• Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial CancerRecruitingNCT05819892Phase 1
• Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated GliomasRecruitingNCT05804227Early Phase 1
• Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma PatientsRecruitingNCT05776979Phase 2
• Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Tissue Nanomechanical Phenotype EvaluationRecruitingNCT05774678Phase 3
• A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell LymphomasRecruitingNCT05773040Phase 1
• Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer SurgeryRecruitingNCT05766891Phase 2/3
• Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base TumorsRecruitingNCT05733091
• Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINACRecruitingNCT05709782Phase 2
• Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain MetastasesRecruitingNCT05704647Phase 2
• Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)RecruitingNCT05700721Phase 2
• Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.RecruitingNCT05694650
• Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and TelegeneticsRecruitingNCT05694559Not applicable
• Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United StatesRecruitingNCT05681026Not applicable
• Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in TexasRecruitingNCT05676450Not applicable
• 3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized TrialRecruitingNCT05674396Phase 2
• A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)RecruitingNCT05673928Phase 2
• The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense BreastsRecruitingNCT05667532Not applicable
• Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.RecruitingNCT05649072Not applicable
• Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic LeukemiaRecruitingNCT05645718Phase 2
• Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian CancerRecruitingNCT05636111Phase 1
• REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)RecruitingNCT05632809Phase 2
• A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHLRecruitingNCT05615636Phase 2
• Precision Optical Guidance for Oral BiopsyRecruitingNCT05554133Not applicable
• Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal MelanomaRecruitingNCT05546827Phase 2
• Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)RecruitingNCT05536349Phase 2
• Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) PatientsRecruitingNCT05529069Phase 2
• Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability TestingRecruitingNCT05497024
• Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)RecruitingNCT05475171Phase 2
• A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell TherapyRecruitingNCT05464719Phase 2
• An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate CancerRecruitingNCT05454488Phase 2
• Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing StrategyRecruitingNCT05431595Phase 2/3
• A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch SyndromeRecruitingNCT05411718Phase 2
• Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast CancerRecruitingNCT05406232
• Rice Technologies for Cervical Cancer Screening and DiagnosisRecruitingNCT05372484Not applicable
• A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess BlastsRecruitingNCT05365035Phase 2
• A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)RecruitingNCT05360160Phase 1/2
• Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis FungoidesRecruitingNCT05357794Phase 2
• A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's LymphomaRecruitingNCT05355051Phase 2
• A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the BrainRecruitingNCT05342454
• First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F-Fluoro-1-Naphthol (18F-4FN) for PET ImagingRecruitingNCT05335811Phase 1
• Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort StudyRecruitingNCT05287451Not applicable
• Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction CancersRecruitingNCT05205343
• Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver MetastasesRecruitingNCT05195710Phase 1
• Molecular Epidemiology of Biliary Tree CancersRecruitingNCT05179486
• Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis GuidelinesRecruitingNCT05143619
• Quality of Life in Patients With Asymptomatic Monoclonal GammopathiesRecruitingNCT05136807
• Quality of Life and Function of Patients With Pelvic Tumors After Undergoing HemipelvectomyRecruitingNCT05134142
• Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic CounselingRecruitingNCT05126810
• Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)RecruitingNCT05123807Phase 2
• Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological MalignancesRecruitingNCT05110742Phase 1/2
• Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related TherapiesRecruitingNCT05108519
• Hypofractionated Radiation Therapy for Merkel Cell CarcinomaRecruitingNCT05100095Phase 2
• Improving Processes of Cancer Care Delivery at a Comprehensive Cancer CenterNot yet recruitingNCT05095948
• Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological MalignancesRecruitingNCT05092451Phase 1/2
• Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxRecruitingNCT05092373Phase 1
• Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple MyelomaRecruitingNCT05091372Phase 2
• Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain MetastasesRecruitingNCT05064280Phase 2
• ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver MetastasesRecruitingNCT05062317Phase 2

← M.D. Anderson Cancer Center overview and focus areas